Compare XHR & PAHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | XHR | PAHC |
|---|---|---|
| Founded | 2007 | 1946 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.7B |
| IPO Year | 2014 | 2014 |
| Metric | XHR | PAHC |
|---|---|---|
| Price | $14.17 | $49.49 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 6 | 3 |
| Target Price | $13.67 | ★ $34.33 |
| AVG Volume (30 Days) | ★ 595.8K | 217.5K |
| Earning Date | 05-27-2026 | 05-06-2026 |
| Dividend Yield | ★ 3.90% | 0.98% |
| EPS Growth | 326.67 | ★ 1883.33 |
| EPS | 0.64 | ★ 1.32 |
| Revenue | ★ $1,078,500,000.00 | $833,350,000.00 |
| Revenue This Year | $4.03 | $17.03 |
| Revenue Next Year | $3.39 | $3.82 |
| P/E Ratio | ★ $22.45 | $37.12 |
| Revenue Growth | 3.80 | ★ 4.12 |
| 52 Week Low | $8.55 | $16.16 |
| 52 Week High | $16.48 | $56.30 |
| Indicator | XHR | PAHC |
|---|---|---|
| Relative Strength Index (RSI) | 34.39 | 50.20 |
| Support Level | $13.65 | $37.09 |
| Resistance Level | $15.29 | $56.14 |
| Average True Range (ATR) | 0.51 | 2.22 |
| MACD | -0.17 | -0.76 |
| Stochastic Oscillator | 2.54 | 35.46 |
Xenia Hotels & Resorts Inc is a real estate investment trust that invests in premium full-service, lifestyle, and urban upscale hotels and resorts across the United States. The company owns and pursues hotels in the upscale, upper upscale, and luxury segments that are affiliated with various brands. Its hotels are operated by Marriott, along with Hilton, Hyatt, Starwood, Kimpton, Aston, Fairmont, and Loews. The firm's properties are located in various regions across the U.S.: the South Atlantic, West South Central, Pacific, Mountain, and other regions. Xenia's revenue is divided between the sale of rooms, food and beverages, and other sources.
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.